GlassScriptPhysician profile
Jennifer Yeung
NPI 1275827719
$7,207.38
in general payments reported to CMS, 2019-2025
14 companies · $3,266 in 2025
The $3,266 reported for 2025 was more than what 88% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2022: $584 · 2023: $1,745 · 2024: $1,216 · 2025: $3,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,674 · Food and Beverage: $1,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,674.33 |
| Food and Beverage | $1,552.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,484.81 | 2022-2025 | Altaviva, Interstim |
| Stryker Corporation | $1,130.52 | 2023 | Chromophare F300, 1788 |
| Karl Storz Endoscopy-America | $975.60 | 2024 | |
| Arthrex, INC. | $831.73 | 2023-2025 | |
| Legacy Ortho LLC | $775.65 | 2023-2025 | |
| Boston Scientific Corporation | $340.47 | 2019-2025 | Lynx System, Advantage System |
| Coloplast Corp | $196.82 | 2019-2025 | |
| Medtronic USA, INC. | $176.68 | 2019 | |
| Axonics, INC. | $133.34 | 2022-2023 | Axonics |
| Abbvie INC. | $68.28 | 2022-2025 | Botox |
| Escala Medical INC. | $27.93 | 2025 | |
| Laborie Medical Technologies Corp. | $25.17 | 2024 | Urgent PC Neuromodulation System |
| Dexcom, INC. | $21.88 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $18.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Yeung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.